Cargando…

Challenges of lung transplantation in India

Lung transplantation (LTx) is the definitive treatment for select progressive end-stage lung disease patients despite being on optimum medical therapy. Asian countries like China, Japan and India have started LTx programmes despite various odds and challenges. Some of these challenges seem to be uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Unmil B., Kumar, Pradeep, Rahulan, Vijil, Dutta, Prabhat, Attawar, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064884/
https://www.ncbi.nlm.nih.gov/pubmed/33935383
http://dx.doi.org/10.1007/s12055-021-01170-9
_version_ 1783682231029465088
author Shah, Unmil B.
Kumar, Pradeep
Rahulan, Vijil
Dutta, Prabhat
Attawar, Sandeep
author_facet Shah, Unmil B.
Kumar, Pradeep
Rahulan, Vijil
Dutta, Prabhat
Attawar, Sandeep
author_sort Shah, Unmil B.
collection PubMed
description Lung transplantation (LTx) is the definitive treatment for select progressive end-stage lung disease patients despite being on optimum medical therapy. Asian countries like China, Japan and India have started LTx programmes despite various odds and challenges. Some of these challenges seem to be unique to developing countries. We have elaborated the challenges of LTx in India and their proposed solutions and shared our experience in setting up a successful LTx programme.
format Online
Article
Text
id pubmed-8064884
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-80648842021-04-26 Challenges of lung transplantation in India Shah, Unmil B. Kumar, Pradeep Rahulan, Vijil Dutta, Prabhat Attawar, Sandeep Indian J Thorac Cardiovasc Surg Review Article Lung transplantation (LTx) is the definitive treatment for select progressive end-stage lung disease patients despite being on optimum medical therapy. Asian countries like China, Japan and India have started LTx programmes despite various odds and challenges. Some of these challenges seem to be unique to developing countries. We have elaborated the challenges of LTx in India and their proposed solutions and shared our experience in setting up a successful LTx programme. Springer Nature Singapore 2021-04-24 2022-07 /pmc/articles/PMC8064884/ /pubmed/33935383 http://dx.doi.org/10.1007/s12055-021-01170-9 Text en © Indian Association of Cardiovascular-Thoracic Surgeons 2021
spellingShingle Review Article
Shah, Unmil B.
Kumar, Pradeep
Rahulan, Vijil
Dutta, Prabhat
Attawar, Sandeep
Challenges of lung transplantation in India
title Challenges of lung transplantation in India
title_full Challenges of lung transplantation in India
title_fullStr Challenges of lung transplantation in India
title_full_unstemmed Challenges of lung transplantation in India
title_short Challenges of lung transplantation in India
title_sort challenges of lung transplantation in india
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064884/
https://www.ncbi.nlm.nih.gov/pubmed/33935383
http://dx.doi.org/10.1007/s12055-021-01170-9
work_keys_str_mv AT shahunmilb challengesoflungtransplantationinindia
AT kumarpradeep challengesoflungtransplantationinindia
AT rahulanvijil challengesoflungtransplantationinindia
AT duttaprabhat challengesoflungtransplantationinindia
AT attawarsandeep challengesoflungtransplantationinindia